Monster Beverage Authorizes New $500M Share Repurchase Program
MNST sits 50% above its 52-week low of $58.09.
Summary
Monster Beverage's board approved a new $500 million share repurchase program, adding to an existing $400 million authorization, signaling strong management confidence and a commitment to shareholder returns.
Key Events · Financing and Capital Events · MNST
-
New Share Repurchase Program Authorized
The Board of Directors authorized a new program for the repurchase of up to an additional $500.0 million of common stock.
-
Total Repurchase Capacity Increased
With $400.0 million remaining from a previously authorized program, the company now has a total of $900.0 million available for share repurchases.
-
Routine Governance Matters Approved
Stockholders re-elected all ten directors, ratified Ernst & Young LLP as the independent auditor, and approved executive compensation on an advisory basis at the annual meeting.
Analysis · MNST · Manufacturing
Monster Beverage's Board of Directors has authorized a new share repurchase program for an additional $500 million. This authorization, combined with the $400 million remaining from a previous program, brings the total available for repurchases to $900 million. This significant capital allocation decision, made while the stock is trading near its 52-week high, signals management's strong confidence in the company's valuation and its commitment to returning capital to shareholders, potentially boosting earnings per share.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 36.9% of the 966 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.66%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MNST was trading at $87.23 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $85.2B. The 52-week trading range was $58.09 to $88.77. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.